Facile indazole-endowed thiadiazole hybrid derivatives as antibacterial, anti-diabetic and thymidine phosphorylase inhibitors: An insight to experimental, in-vitro biological potential and computational approaches

Sabeen Arshad; Aneela Maalik; Wajid Rehman; Yousaf Khan; Mohammed M. Alanazi; Hina Sarfraz; Liaqat Rasheed

doi:10.1007/s44446-025-00003-9

Q1 2025

Facile indazole-endowed thiadiazole hybrid derivatives as antibacterial, anti-diabetic and thymidine phosphorylase inhibitors: An insight to experimental, in-vitro biological potential and computational approaches

Sabeen Arshad · Aneela Maalik · Wajid Rehman · Yousaf Khan · Mohammed M. Alanazi · Hina Sarfraz · Liaqat Rasheed

10.1007/s44446-025-00003-9 390 Views 18 Citations

Citations

390

Views

Abstract not available for this publication.

Cite this Article (APA)

Sabeen, A., Aneela, M., Wajid, R., Yousaf, K., Mohammed, M. A., Hina, S., Liaqat, R. (2025). Facile indazole-endowed thiadiazole hybrid derivatives as antibacterial, anti-diabetic and thymidine phosphorylase inhibitors: An insight to experimental, in-vitro biological potential and computational approaches. Saudi Pharmaceutical Journal. https://doi.org/10.1007/s44446-025-00003-9